Order Article Reprints

Schönrock M, Sonnemann P, Michalowski N, Heuser M, Thol F, Ayuk FA, Wolschke C, Klyuchnikov E, Bokemeyer C, Fiedler W, et al. Dose-Reduced FLA-IDA in Combination with Venetoclax Is an Effective and Safe Salvage Therapy in Relapsed and Refractory Acute Myeloid Leukemia (R/R AML). Cancers. 2024; 16(22):3872. https://doi.org/10.3390/cancers16223872

Schönrock, Martin, Piet Sonnemann, Nina Michalowski, Michael Heuser, Felicitas Thol, Francis Ayuketang Ayuk, Christine Wolschke, Evgeny Klyuchnikov, Carsten Bokemeyer, Walter Fiedler, and et al. 2024. "Dose-Reduced FLA-IDA in Combination with Venetoclax Is an Effective and Safe Salvage Therapy in Relapsed and Refractory Acute Myeloid Leukemia (R/R AML)" Cancers 16, no. 22: 3872. https://doi.org/10.3390/cancers16223872

Schönrock, M., Sonnemann, P., Michalowski, N., Heuser, M., Thol, F., Ayuk, F. A., Wolschke, C., Klyuchnikov, E., Bokemeyer, C., Fiedler, W., & Cichutek, S. (2024). Dose-Reduced FLA-IDA in Combination with Venetoclax Is an Effective and Safe Salvage Therapy in Relapsed and Refractory Acute Myeloid Leukemia (R/R AML). Cancers, 16(22), 3872. https://doi.org/10.3390/cancers16223872